by Ubaka Ogbogu | Dec 16, 2010
Chris Kamel’s recent post on chemically derived transcription factors for iPS cell production is very exciting for a variety of non-scientific reasons. Most notably, the innovative procedure and future improvements are likely to ease ethical, safety and legal concerns...
by Chris Kamel | Dec 9, 2010
Induced pluripotent stem (iPS) cells are generally created by the expression of a small number of key genes to reprogram adult cells into an undifferentiated, pluripotent state. Because some of the transcription factors used for reprogramming are oncogenes, as well as...
by David Kent | Dec 7, 2010
My last post was mostly centred on the lack of openness displayed by a growing number of scientists, but failed to comment on the wonderful array of findings that were presented by world leaders in stem cell biology. The Royal Society Meeting that took place in...
by Stem Cell Network | Nov 23, 2010
It may be cold in Calgary but there’s plenty of warmth and amicable conversation at the Stem Cell Network annual meeting. Day 1 opened with an afternoon plenary featuring some impressive talks. Peter Lansdorp of the BC Cancer Agency gave an overview of his...
by Paul Krzyzanowski | Nov 17, 2010
In a previous post, Chris Kamel recently reviewed the Nature article about direct creation of blood progenitors from skin fibroblasts as discovered by Mick Bhatia’s research group. The fascinating thing about this article is the potential for enabling autologous...
Comments